@misc{indiciaec9eb5ab90992,
  title = {A phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-2106, an anti-CD40 antibody, following single intravenous or subcutaneous administration in healthy participants.},
  author = {Jie Huang and Qiang-da Huang and Jin-Lian Xie and Qian Wu and Kun-Hong Deng and Shuang Yang and Xiao-Yan Yang and Ying Wang and Ying Zhu and Qiuna Du and Chuanpin Chen and Guo-Ping Yang},
  year = {2026},
  doi = {10.1016/j.ejphar.2026.179291},
  url = {https://pubmed.ncbi.nlm.nih.gov/42648529/},
  note = {Source identifier: 42648529}
}